CNO — California Nanotechnologies Income Statement

0.000.00%

Last trade - 00:00

IndustrialsSpeculativeMicro CapNeutral

Annual income statement for California Nanotechnologies, fiscal year end - February 28th, USD millions except per share, conversion factor applied.

	2022 February 28th	2023 February 28th	2024 February 29th	2025 February 28th	2026 February 28th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1.08	1.38	3.34	6.22	2.79
Cost of Revenue
Gross Profit	0.757	0.998	2.33	4.59	1.5
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	0.872	1.19	2.7	4.84	4.78
Operating Profit	0.21	0.189	0.635	1.38	-1.99
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.201	0.084	0.382	0.011	-1.85
Provision for Income Taxes
Net Income After Taxes	0.201	0.08	0.382	-0.158	-1.86
Net Income Before Extraordinary Items
Net Income	0.201	0.08	0.382	-0.158	-1.86
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.201	0.08	0.382	-0.158	-1.86
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.006	0.002	0.01	-0.004	-0.041